TrialCancer research communications2026

A Phase II Study of Berzosertib in Combination with Carboplatin Compared with Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer.

Atish D Choudhury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.